kabutan

TSUMURA & CO.(4540) Summary

4540
TSE Prime
TSUMURA & CO.
4,015
JPY
+26
(+0.65%)
Jan 29, 3:30 pm JST
26.24
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
12.2
PBR
1.01
Yield
3.59%
Margin Trading Ratio
6.74
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
3,974 JPY 25.95 USD
Previous Close Jan 28
3,989 JPY 26.13 USD
High Jan 29, 3:30 pm
4,015 JPY 26.24 USD
Low Jan 29, 9:22 am
3,936 JPY 25.72 USD
Volume
240,300
Trading Value
0.96B JPY 6.27M USD
VWAP
3988.9 JPY 26.08 USD
Minimum Trading Value
401,500 JPY 2,624 USD
Market Cap
0.31T JPY 2.03B USD
Number of Trades
982
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
High
1-Year Average
1,456
1-Year High May 13, 2025
8,192
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 31,900 119,200 3.74
Jan 16, 2026 37,600 109,000 2.90
Jan 9, 2026 33,600 109,400 3.26
Dec 26, 2025 34,900 121,700 3.49
Dec 19, 2025 55,600 140,500 2.53
Company Profile
TSUMURA & CO. is the leading company specializing in Kampo medicines, expanding its focus on medications for the elderly, cancer patients, and women's health. The company is also developing its business in China.
Sector
Pharmaceuticals
TSUMURA & CO. primarily engages in the manufacture and sale of Kampo medicines, offering both prescription and over-the-counter pharmaceuticals. The company has established an integrated production system from the cultivation of raw medicinal herbs to product manufacturing, ensuring thorough quality control. In Japan, TSUMURA & CO. has secured its position as the undisputed top manufacturer of prescription Kampo preparations. In recent years, the company has been actively expanding into the Chinese market, strengthening its local production and sales capabilities through capital and business alliances with local enterprises. Furthermore, TSUMURA & CO. is advancing its global business operations, including drug development in the United States and cultivation of raw medicinal herbs in Laos. The company focuses on promoting Kampo medicine and developing evidence-based Kampo preparations to address the diversifying needs in healthcare.